Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,319,702 | 2,391,050 | 2,863,619 | 2,777,334 | 2,518,142 |
| Marketable Securities | 28,181 | 31,192 | 349,978 | 377,147 | 572,285 |
| Receivables | 4,369,885 | 4,111,328 | 3,577,397 | 3,595,674 | 3,216,014 |
| Inventories | 2,644,386 | 2,497,774 | 2,335,159 | 2,131,073 | 1,898,390 |
| Other current assets | 0 | 1 | -1 | 0 | 1 |
| TOTAL | $9,362,154 | $9,031,345 | $9,126,152 | $8,881,228 | $8,204,832 |
| Non-Current Assets | |||||
| PPE Net | 7,577,595 | 6,405,134 | 5,354,020 | 4,484,600 | 3,801,096 |
| Investments And Advances | 271,019 | 271,092 | 267,648 | 326,474 | 319,920 |
| Intangibles | 874,667 | 786,671 | 505,068 | 403,300 | 321,110 |
| Other Non-Current Assets | 743,803 | 442,340 | 294,838 | 398,693 | 1,012,733 |
| TOTAL | $9,467,084 | $7,905,236 | $6,421,573 | $5,613,068 | $5,454,859 |
| Total Assets | $18,829,240 | $16,936,580 | $15,547,720 | $14,494,290 | $13,659,690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 220,953 | 78,744 | 257,319 | 34,029 | 159,662 |
| Accounts payable and accrued liabilities | 953,064 | 1,032,992 | 852,159 | 893,235 | 733,138 |
| Other current liabilities | 7,036,156 | 6,465,071 | 5,393,969 | 5,530,892 | 4,627,085 |
| TOTAL | $8,841,552 | $8,281,676 | $7,147,807 | $7,048,990 | $6,081,902 |
| Non-Current Liabilities | |||||
| Long Term Debt | 451,049 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 891,455 | 710,679 | 704,512 | 716,401 | 587,909 |
| TOTAL | $1,354,496 | $728,721 | $833,020 | $718,332 | $588,802 |
| Total Liabilities | $10,196,050 | $9,010,397 | $7,980,826 | $7,767,322 | $6,670,704 |
| Shareholders' Equity | |||||
| Common Shares | 71,952 | 74,921 | 75,950 | 75,786 | 77,376 |
| Retained earnings | 8,666,769 | 8,165,777 | 7,439,606 | 6,852,095 | 6,966,221 |
| Other shareholders' equity | -104,531 | -312,515 | 53,342 | -199,907 | -53,610 |
| TOTAL | $8,633,190 | $7,926,183 | $7,566,898 | $6,726,974 | $6,988,987 |
| Total Liabilities And Equity | $18,829,240 | $16,936,580 | $15,547,724 | $14,494,296 | $13,659,691 |